Oura's confidential IPO filing in May 2026, following its October 2025 Series E round at an $11 billion post-money valuation led by Fidelity, anchors trader sentiment amid projected 2026 revenue approaching $2 billion from roughly $500 million prior. This positions the company at a forward price-to-sales multiple near 5.5x based on growth in paid memberships exceeding 5 million and expansion into AI-driven health insights, though broader equity market conditions, SEC review timelines, and comparable wearable or medtech multiples introduce variability in the final closing market cap. With leading outcomes clustered between sub-$7.5 billion and $20 billion-plus ranges, sentiment reflects uncertainty over whether strong revenue momentum and competitive differentiation in subscription-based wearables will support a premium valuation or face dilution from macroeconomic factors and regulatory hurdles before a potential 2027 listing.
基于Polymarket数据的AI实验性摘要。这不是交易建议,也不影响该市场的结算方式。 · 更新于No IPO before January 2027 17.3%
<$7.5B 14%
$10B–$12.5B 14%
$20B+ 14%
$198,638 交易量
$198,638 交易量
<$7.5B
14%
$7.5B–$10B
6%
$10B–$12.5B
14%
$12.5B–$15B
11%
$15B–$17.5B
13%
$17.5B–$20B
12%
$20B+
14%
No IPO before January 2027
10%
No IPO before January 2027 17.3%
<$7.5B 14%
$10B–$12.5B 14%
$20B+ 14%
$198,638 交易量
$198,638 交易量
<$7.5B
14%
$7.5B–$10B
6%
$10B–$12.5B
14%
$12.5B–$15B
11%
$15B–$17.5B
13%
$17.5B–$20B
12%
$20B+
14%
No IPO before January 2027
10%
If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
市场开放时间: May 26, 2026, 12:28 PM ET
Resolver
0x69c47De9D...If no IPO occurs by December 31, 2026, 11:59 PM ET, the market will resolve to "No IPO before January 2027".
Market capitalization expresses the monetary value of a company’s outstanding shares, stated in its pricing currency. It is calculated as the number of shares outstanding multiplied by the closing share price on the first trading day.
If the relevant value falls exactly between two brackets, then this market will resolve to the higher range bracket.
Resolution will be based on the primary exchange’s official listing page. In the event that the relevant figure is not displayed, another reliable source will be used.
In the event of an interruption in the course of the normal trading session on Oura’s first day of trading (e.g., a circuit breaker or half-day), the market will resolve according to the official closing price of the abbreviated session. If no such official closing price is published, the market will resolve according to the next trading day on which an official closing price is published, treating that as the first day of trading for purposes of this market.
Resolver
0x69c47De9D...Oura's confidential IPO filing in May 2026, following its October 2025 Series E round at an $11 billion post-money valuation led by Fidelity, anchors trader sentiment amid projected 2026 revenue approaching $2 billion from roughly $500 million prior. This positions the company at a forward price-to-sales multiple near 5.5x based on growth in paid memberships exceeding 5 million and expansion into AI-driven health insights, though broader equity market conditions, SEC review timelines, and comparable wearable or medtech multiples introduce variability in the final closing market cap. With leading outcomes clustered between sub-$7.5 billion and $20 billion-plus ranges, sentiment reflects uncertainty over whether strong revenue momentum and competitive differentiation in subscription-based wearables will support a premium valuation or face dilution from macroeconomic factors and regulatory hurdles before a potential 2027 listing.
基于Polymarket数据的AI实验性摘要。这不是交易建议,也不影响该市场的结算方式。 · 更新于


警惕外部链接哦。
警惕外部链接哦。
常见问题